Fructose intake driver of obesity, just like in hibernating animals, study finds
Researchers at the University of Colorado Anschutz Medical Campus have officially identified a central conduit to obesity: fructose.
Aug 1, 2023
0
168
Researchers at the University of Colorado Anschutz Medical Campus have officially identified a central conduit to obesity: fructose.
Aug 1, 2023
0
168
Scientists at the University of Colorado Anschutz Medical Campus have discovered what they believe to be the central mechanism behind cognitive decline associated with normal aging.
Jul 25, 2023
0
262
A new study published in Gastroenterology aims to improve the effectiveness of screening and surveillance practices for early cancer detection in Barrett's esophagus (BE).
Jul 20, 2023
0
7
People with Down syndrome, the condition caused by an extra copy of chromosome 21, or trisomy 21, display chronic dysregulation of their immune system, which can contribute to high rates of autoimmune conditions and severe ...
Jul 17, 2023
0
47
Researchers at the University of Colorado Anschutz Medical Campus have found that cannabidiol (CBD), often used to treat anxiety and nausea, can potentially harm a developing fetus. The paper was published in Molecular Psychiatry.
Jul 13, 2023
0
75
A new study published in the JNCI: Journal of the National Cancer Institute brings researchers and oncologists one step closer to better understanding the complexities of PD-1 inhibitors, a common type of immunotherapy, and ...
Jul 6, 2023
0
2
Researchers at the University of Colorado Anschutz Medical Campus have found that vaping nicotine during pregnancy may be no safer for a developing fetus than smoking cigarettes. The study suggests that vaping nicotine interferes ...
Jul 5, 2023
0
2
Researchers from the University of Colorado Anschutz Medical Campus have identified a potential new immune checkpoint receptor that could lead to treatments for diseases such as lung and bowel cancer and autoimmune conditions ...
Jun 30, 2023
0
66
Benzodiazepine use and discontinuation is associated with nervous system injury and negative life effects that continue after discontinuation, according to a new study from researchers at the University of Colorado Anschutz ...
Jun 28, 2023
1
121
An article published in the The Lancet Neurology journal evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.
Jun 23, 2023
0
30